Free Trial
→ Stranded On The Flood Plains of History (From Porter & Company) (Ad)tc pixel Free ABBV Stock Alerts

AbbVie (ABBV) Short Interest Ratio & Short Volume

AbbVie logo
$227.54 +2.77 (+1.23%)
Closing price 03:59 PM Eastern
Extended Trading
$226.28 -1.27 (-0.56%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

AbbVie Short Interest Overview

As of May 29, 2026, AbbVie (ABBV) had a short interest of 23.16 million shares sold short, representing 1.31% of the public float. This marks a 2.52% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.3, meaning it would take 4.3 days of the average trading volume of 6.75 million shares to cover all short positions.

Current Short Interest
23,158,744 shares
Previous Short Interest
22,590,034 shares
Change Vs. Previous Month
2.52%
Dollar Volume Sold Short
$5.04 billion
Short Interest Ratio
4.3 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
1,766,790,000 shares
Short Percent of Float
1.31%
Today's Trading Volume
4,084,474 shares
Average Trading Volume
6,754,198 shares
Today's Volume Vs. Average
60%
Short Selling AbbVie?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

AbbVie Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202623,158,744 shares $5.04 billion +2.5%1.3%4.27 $217.83
5/15/202622,590,034 shares $4.76 billion +8.1%1.3%3.98 $210.54
4/30/202620,907,964 shares $4.43 billion -4.3%1.2%2.71 $211.66
4/15/202621,845,453 shares $4.56 billion +8.6%1.2%3.71 $208.58
3/31/202620,125,180 shares $4.37 billion -19.9%1.1%2.45 $217.39
3/13/202625,110,220 shares $5.52 billion +15.5%1.4%3.7 $219.73
2/27/202621,748,668 shares $5.04 billion -4.9%1.2%3.61 $231.69
2/13/202622,876,092 shares $5.30 billion +16.2%1.3%2.74 $231.57
1/30/202619,684,551 shares $4.39 billion -10.7%1.1%2.77 $223.02
1/15/202622,042,536 shares $4.78 billion +11.9%1.2%2.94 $216.66
12/31/202519,705,568 shares $4.50 billion +9.0%1.1%3.84 $228.55
12/15/202518,075,534 shares $4.11 billion -0.7%1.0%3.58 $227.53
11/28/202518,209,156 shares $4.13 billion -2.8%1.0%2.87 $226.72
11/14/202518,724,102 shares $4.35 billion -0.9%1.1%2.99 $232.43
10/31/202518,891,139 shares $4.12 billion +4.5%1.1%3.71 $218.14
10/15/202518,080,000 shares $4.09 billion +11.0%1.0%3.3 $226.31
9/30/202516,290,000 shares $3.77 billion -1.6%0.9%3 $231.47
9/15/202516,560,000 shares $3.61 billion +7.5%0.9%3 $217.92
8/31/202515,400,000 shares $3.24 billion -9.4%0.9%2.8 $210.25
8/15/202517,000,000 shares $3.51 billion +12.4%1.0%3 $206.65
7/31/202515,130,000 shares $2.86 billion -3.1%0.9%2.4 $189.02
7/15/202515,610,000 shares $2.91 billion -2.1%0.9%2.4 $186.56
6/30/202515,950,000 shares $2.96 billion +8.5%0.9%2.1 $185.80
6/15/202514,700,000 shares $2.80 billion -7.5%0.8%2 $190.67
5/31/202515,890,000 shares $2.95 billion -20.3%0.9%2.1 $185.53
5/15/202519,930,000 shares $3.62 billion +0.7%1.1%2.5 $181.52
4/30/202519,800,000 shares $3.86 billion +17.6%N/A2.6 $195.15
4/15/202516,840,000 shares $2.98 billion -1.8%1.0%2.3 $176.84
3/31/202517,140,000 shares $3.60 billion -13.0%1.0%2.4 $209.83
3/15/202519,700,000 shares $4.17 billion +6.4%1.1%3.1 $211.90
2/28/202518,510,000 shares $3.87 billion -5.7%1.1%3 $209.07
2/15/202519,620,000 shares $3.79 billion +3.7%1.1%3.3 $193.00
1/31/202518,930,000 shares $3.48 billion +4.2%1.1%2.9 $183.90
1/15/202518,160,000 shares $3.11 billion +6.8%N/A2.8 $171.32
12/31/202417,000,000 shares $3.02 billion -8.3%N/A2.7 $177.70
12/15/202418,530,000 shares $3.21 billion -4.1%N/A3 $173.37
11/30/202419,320,000 shares $3.53 billion -4.2%N/A3.3 $182.93
11/15/202420,170,000 shares $3.33 billion +11.3%N/A3.5 $164.91
10/31/202418,130,000 shares $3.70 billion +12.1%N/A3.7 $203.87
10/15/202416,180,000 shares $3.10 billion +8.9%0.9%3.4 $191.86
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
9/30/202414,860,000 shares $2.93 billion -16.5%0.8%3.2 $197.48
9/15/202417,790,000 shares $3.45 billion -8.7%1.0%3.5 $194.21
8/31/202419,490,000 shares $3.83 billion -3.5%1.1%3.7 $196.31
8/15/202420,190,000 shares $3.90 billion +15.2%1.2%3.7 $193.40
7/31/202417,530,000 shares $3.25 billion +7.0%1.0%3.2 $185.32
7/15/202416,380,000 shares $2.75 billion +1.0%0.9%3 $168.03
6/30/202416,220,000 shares $2.78 billion +6.4%0.9%3 $171.52
6/15/202415,250,000 shares $2.57 billion -7.5%0.9%2.9 $168.59
5/31/202416,490,000 shares $2.66 billion +3.5%0.9%2.9 $161.19
5/15/202415,930,000 shares $2.61 billion +10.0%0.9%2.9 $163.78
4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69
4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67
3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10
3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88
2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61
2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61
1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36
1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40
12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97
12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07
11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35
11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61
10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18
10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96
9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06
9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09
8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96
8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12
7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58
7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01
6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72
6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89
5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96
5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59
4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12
4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59
3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37
3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06
2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90
2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06
1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75
1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60
12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61
12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10
11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18
11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04
10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40
10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94
9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21
9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
8/31/202211,380,000 shares $1.53 billion -12.5%N/A2.1 $134.46
8/15/202213,010,000 shares $1.85 billion -6.1%N/A2.2 $142.29
7/31/202213,850,000 shares $1.99 billion -1.3%0.8%2.2 $143.51
7/15/202214,030,000 shares $2.16 billion -2.7%0.8%2.1 $153.62
6/30/202214,420,000 shares $2.21 billion +6.7%1.0%2 $153.16
6/15/202213,520,000 shares $1.87 billion +6.0%0.9%1.9 $138.09
5/31/202212,750,000 shares $1.88 billion -10.4%0.7%1.8 $147.37
5/15/202214,230,000 shares $2.18 billion +8.2%0.8%1.9 $153.50
4/30/202213,150,000 shares $1.93 billion +9.0%0.8%1.7 $146.88
4/15/202212,070,000 shares $1.96 billion -10.2%0.7%1.5 $162.31
3/31/202213,440,000 shares $2.18 billion -9.7%0.8%1.7 $162.11
3/15/202214,890,000 shares $2.32 billion -6.9%N/A1.9 $155.88
2/28/202215,990,000 shares $2.36 billion +3.9%N/A2 $147.77
2/15/202215,390,000 shares $2.23 billion -4.7%N/A2 $144.76
1/31/202216,150,000 shares $2.21 billion +12.7%0.9%2.3 $136.89
1/15/202214,330,000 shares $1.95 billion -13.7%0.8%2.2 $135.87
12/31/202116,610,000 shares $2.25 billion +7.6%0.9%2.7 $135.40
12/15/202115,440,000 shares $2.01 billion +9.4%0.9%2.5 $130.23
11/30/202114,120,000 shares $1.63 billion +0.2%N/A2.3 $115.28
11/15/202114,090,000 shares $1.65 billion +3.5%0.8%2 $116.84
10/29/202113,620,000 shares $1.56 billion +18.5%0.8%1.9 $114.67
10/15/202111,490,000 shares $1.26 billion -16.0%0.7%1.6 $109.33
9/30/202113,670,000 shares $1.47 billion +5.2%0.8%1.9 $107.87
9/15/202112,990,000 shares $1.40 billion -4.1%0.7%1.9 $107.77
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83

ABBV Short Interest - Frequently Asked Questions

Short interest is the volume of AbbVie shares that have been sold short but have not yet been closed out or covered. As of May 29th, investors have sold 23,158,744 shares of ABBV short. 1.31% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 4.3. Learn More on AbbVie's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Hsbc Holdings PLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of AbbVie's floating shares are currently sold short.

AbbVie saw a increase in short interest in May. As of May 29th, there was short interest totaling 23,158,744 shares, an increase of 2.5% from the previous total of 22,590,034 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.31% of AbbVie's shares are currently sold short. Here is how the short interest of companies compare to AbbVie: Amgen Inc. (2.21%), Gilead Sciences, Inc. (2.08%), Moderna, Inc. (16.33%), Abbott Laboratories (1.27%), Astrazeneca Plc (0.11%), Bristol Myers Squibb Company (1.89%), Johnson & Johnson (0.97%), Eli Lilly and Company (1.04%), Merck & Co., Inc. (1.24%), Pfizer Inc. (2.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading up $2.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ABBV:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:ABBV) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
BUY THIS: Claim a backdoor stake in SpaceX
There may be a way to claim pre-IPO exposure to SpaceX before it ever hits public markets - using a simple tra...
Chaikin Analytics | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This Is How Financial Freedom Dies—And Most People Never See It Coming
While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...
Priority Gold | Sponsoredtc pixel